Studies on the antibacterial activity of 1-substituted 1,4-dihydro-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,8-naphthyridine derivatives.
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects; D004352:Drug Resistance, Microbial; D005658:Fungi / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008826:Microbial Sensitivity Tests; D009287:Naphthyridines / Q000494:pharmacology / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy; D012481:Salmonella Infections, Animal / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D009287:Naphthyridines